Weiss Asset Management LP Makes New Investment in Globe Life Inc. $GL

Weiss Asset Management LP bought a new stake in shares of Globe Life Inc. (NYSE:GLFree Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 19,005 shares of the company’s stock, valued at approximately $2,645,000.

Several other hedge funds have also made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Globe Life by 6.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after acquiring an additional 607 shares during the period. NewEdge Advisors LLC grew its holdings in Globe Life by 368.1% during the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock worth $897,000 after acquiring an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Globe Life by 11.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after purchasing an additional 58,163 shares during the period. Empowered Funds LLC purchased a new position in Globe Life during the 1st quarter valued at about $428,000. Finally, Focus Partners Wealth increased its position in Globe Life by 8.3% during the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after purchasing an additional 656 shares during the period. 81.61% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

GL has been the subject of several research reports. Piper Sandler upped their price target on shares of Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 15th. JPMorgan Chase & Co. lifted their price objective on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. Truist Financial lifted their price objective on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. Keefe, Bruyette & Woods reduced their price objective on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research note on Friday. Finally, Jefferies Financial Group upped their target price on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a report on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Globe Life has a consensus rating of “Moderate Buy” and an average price target of $187.40.

View Our Latest Stock Report on Globe Life

Globe Life Price Performance

Shares of GL opened at $173.64 on Monday. The company has a market cap of $13.48 billion, a price-to-earnings ratio of 11.53 and a beta of 0.47. Globe Life Inc. has a twelve month low of $127.85 and a twelve month high of $191.55. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. The company has a 50 day moving average of $169.07 and a two-hundred day moving average of $152.99.

Globe Life (NYSE:GLGet Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). The firm had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.Globe Life’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, analysts predict that Globe Life Inc. will post 15.7 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a $0.33 dividend. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is presently 8.76%.

Globe Life News Roundup

Here are the key news stories impacting Globe Life this week:

  • Positive Sentiment: Keefe, Bruyette & Woods trimmed its price target only modestly to $190 from $192 and kept an outperform rating, implying roughly 9% upside from recent levels. Benzinga article
  • Positive Sentiment: TD Cowen also reiterated a bullish view, forecasting strong price appreciation for Globe Life (GL). American Banking News article
  • Positive Sentiment: Management raised its 2026 net operating EPS guidance to $15.55-$15.95 and lifted share repurchases to $670 million-$700 million, signaling confidence in future earnings and capital returns. Seeking Alpha article
  • Neutral Sentiment: Globe Life’s Q2 revenue came in roughly in line with expectations, and underwriting income remained strong, showing the core business is still performing acceptably despite some headwinds. Reuters article
  • Negative Sentiment: Q2 earnings of $3.61 per share missed the consensus estimate of $3.67, and several reports pointed to softer sales and rising expenses as reasons for investor concern. MSN article

Insiders Place Their Bets

In related news, CEO James Matthew Darden sold 4,663 shares of the business’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total transaction of $717,542.44. Following the transaction, the chief executive officer directly owned 58,451 shares in the company, valued at $8,994,439.88. The trade was a 7.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Frank M. Svoboda sold 20,000 shares of the company’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $156.68, for a total value of $3,133,600.00. Following the transaction, the chief executive officer directly owned 54,020 shares in the company, valued at $8,463,853.60. This represents a 27.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 90,187 shares of company stock valued at $14,299,874 in the last 90 days. Corporate insiders own 2.11% of the company’s stock.

About Globe Life

(Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Featured Articles

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GLFree Report).

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.